10x Genomics, Inc. TXG Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from 10x Genomics, Inc.’s reported figures.
The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about 10x Genomics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is 10x Genomics, Inc.'s free cash flow?
- 10x Genomics, Inc. (TXG) reported free cash flow of $24.52M in Q1 2026.
- How has 10x Genomics, Inc.'s free cash flow changed year-over-year?
- 10x Genomics, Inc.'s free cash flow decreased by 24.4% year-over-year, from $32.46M to $24.52M.
- What is the long-term trend for 10x Genomics, Inc.'s free cash flow?
- Over 2 years (2021 to 2025), 10x Genomics, Inc.'s free cash flow has grown at a 3.0% compound annual growth rate (CAGR), from -$122.65M to $130.12M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.